How To Research Fentanyl Citrate Injection Formulations UK Online

May 15, 2026

Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview

Fentanyl citrate stays among the most vital tools in contemporary anaesthesia and severe pain management across the United Kingdom. As a potent artificial opioid, its role in the National Health Service (NHS) and personal surgical sectors is well-established, primarily due to its fast start of action and cardiovascular stability. This article provides an extensive overview of fentanyl citrate injection solutions offered in the UK, their medical indicators, regulatory landscape, and administration procedures.

What is Fentanyl Citrate?

Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. It was very first manufactured in 1960 and rapidly ended up being a foundation of perioperative care. In regards to potency, fentanyl is around 50 to 100 times more potent than morphine. Its high lipophilicity permits it to cross the blood-brain barrier rapidly, resulting in a practically immediate analgesic effect when administered intravenously.

In the UK, fentanyl citrate is primarily used by means of the parenteral path (injection) for both sedative and analgesic functions. It works mainly by binding to the mu-opioid receptors in the main nerve system, altering the understanding of discomfort and the emotional reaction to it.

Clinical Indications in the UK

According to the British National Formulary (BNF), fentanyl citrate injection is indicated for several particular clinical scenarios:

Analgesic Action: Used throughout short personnel procedures and in the recovery room.
Analgesic Supplement: Used during the induction and upkeep of inhalation anaesthesia.
Neuroleptanalgesia: Often utilized in mix with a neuroleptic (such as droperidol) to attain a state of quiescence and lowered awareness.
Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
Pre-medication: To offer sedation and analgesia before the induction of basic anaesthesia.

Readily Available Formulations and Strengths in the UK

The UK market uses a number of solutions of fentanyl citrate, created to meet the varying requirements of surgical and emergency situation departments. These are usually provided as clear, colourless solutions for injection or infusion.

Table 1: Common Fentanyl Citrate Formulations in the UK

Strength (Fentanyl base)

Presentation

Common Packaging

Maker Examples

50 micrograms/ml

2 ml Ampoule

Load of 10

Hameln, Advanz Pharma

50 micrograms/ml

10 ml Ampoule

Load of 5 or 10

Hameln, Wockhardt

50 micrograms/ml

20 ml Vial/Ampoule

Load of 5

Hameln, Generic

50 micrograms/ml

50 ml Vial

Individual/Pack of 1

Generic (ICU usage)

Note: While 50 mcg/ml is the standard concentration, specialised solutions for epidural or intrathecal usage may sometimes be prepared by healthcare facility pharmacies under specific procedures.

Pharmacokinetics and Pharmacodynamics

Understanding how the body processes fentanyl is important for safe administration.

Onset of Action: When administered intravenously, the effect begins almost immediately, though the optimum analgesic result may take 3 to 5 minutes.
Period: A single intravenous dose of 100 micrograms usually lasts for 30 to 60 minutes.
Metabolic process: Fentanyl is mainly metabolised in the liver by means of the CYP3A4 enzyme system.
Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, primarily as metabolites.

Administration Protocols

In the UK, the administration of fentanyl citrate is strictly managed and typically performed by anaesthetists or trained specialists in controlled environments.

Dosage Guidelines

Dose must be horizontal and individualised based upon the patient's age, weight, physical status, underlying pathological condition, usage of other drugs, and the type of surgical treatment.

Low Dose (2 mcg/kg): Useful for small surgeries.
Moderate Dose (2— 20 mcg/kg): Used when surgery is more intrusive; requires respiratory monitoring.
High Dose (20— 50 mcg/kg): Used during “hassle-free” significant surgeries (e.g., open-heart surgical treatment) to protect the myocardium from the metabolic needs of tension.

Paths of Administration

Intravenous (IV) Bolus: Common for induction.
Intravenous Infusion: Used for longer treatments or in the ICU.
Intramuscular (IM): Less common, but used for pre-medication in specific circumstances.

Regulative Status and Safety

In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).

Statutory Requirements for UK Hospitals:

Safe Custody: Must be kept in a locked managed drug cupboard.
Record Keeping: Every administration needs to be tape-recorded in a Controlled Drugs Register (CDR).
Damage: Surplus or ended fentanyl needs to be denatured and witnessed by authorised personnel.

Negative Effects and Adverse Reactions

While highly reliable, fentanyl citrate brings a threat of substantial negative effects.

Breathing Depression: The most severe adverse effects, which can lead to breathing arrest if not kept track of.
Bradychardia: Often managed with atropine.
Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation tough, requiring the usage of neuromuscular blocking representatives.
Queasiness and Vomiting: Common in the postoperative period.
Hypotension: Although more stable than morphine, it can still happen, specifically in hypovolaemic clients.

Contrast with Other Opioids

Clinicians frequently pick fentanyl over other opioids due to its particular pharmacokinetic profile.

Table 2: Comparison of Parenteral Opioids in UK Practice

Feature

Fentanyl

Morphine

Remifentanil

Relative Potency

100

100-200

Start

1— 3 minutes

15— 30 minutes

1 minute

Period of Action

30— 60 minutes

3— 4 hours

5— 10 minutes

Histamine Release

Minimal

Considerable

Minimal

Primary Use

Intraoperative/ICU

Post-operative/Chronic

Titratable Infusion

Frequently Asked Questions (FAQ)

1. Is fentanyl citrate injection the exact same as the fentanyl patches?

No. While they contain the very same active drug, the injection is for immediate, intense usage in surgical or emergency settings. Patches (transdermal shipment) are developed for persistent, long-lasting pain management and launch the medication slowly over 72 hours.

2. Fentanyl Citrate Injection UK be used for children in the UK?

Yes, it is regularly utilized in paediatric anaesthesia. However, the dosage must be strictly calculated based upon the kid's weight, and they should be monitored carefully for respiratory anxiety.

3. What is the antagonist for fentanyl?

Naloxone is the particular medicinal antagonist used to reverse the impacts of fentanyl, consisting of breathing depression. In UK health centers, naloxone needs to always be easily offered any place fentanyl is administered.

4. Why is it used over morphine in heart surgery?

Fentanyl is chosen in cardiac surgery since it does not trigger the release of histamine, which can result in vasodilation and hypotension. It offers cardiovascular stability even at high doses.

5. What are the storage requirements?

Fentanyl citrate injection need to be saved listed below 25 ° C and protected from light. As a Schedule 2 drug, it should be kept in a lawfully compliant CD cupboard.

Fentanyl citrate injection formulations are essential components of the UK's medical toolkit for managing perioperative discomfort and assisting in complex surgeries. Its high potency and rapid beginning offer unrivaled precision for anaesthetists, provided that strenuous tracking and regulatory requirements are kept. By comprehending the various concentrations and the strict procedures surrounding its use, healthcare professionals ensure that this effective medication remains both safe and reliable for patients across the country.

Disclaimer: This short article is for informational functions only and does not constitute medical recommendations. Health care specialists must always describe the Summary of Product Characteristics (SmPC) and current BNF guidelines for the most updated recommending details.